March 21 (Reuters) - Becton Dickinson ( BDX ) said on

Thursday that it will increase production of medical syringes in

the United States.

The company said since the initial U.S. Food and Drug

Administration safety communication in November, it has

increased manufacturing of syringes in its Nebraska and

Connecticut facilities.

The FDA in

November

said that it is looking into reports of leaks, breakages

and other quality problems with plastic syringes manufactured in

China and that it may prevent such syringes from entering the

U.S. market if necessary.

(Reporting by Sneha S K; Editing by Tasim Zahid and Varun H K)